Evaluation of Hospital Admission Status for Emergency Department Patients Seen for Chronic Obstructive Pulmonary Disease Exacerbation: A Retrospective Observational Study

REFERENCES

1. 1.↵
   1. Adeloye D,
   2. Chua S,
   3. Lee C

   , et al; Global Health Epidemiology Reference Group (GHERG). Global and regional estimates of COPD prevalence: systematic review and meta-analysis. J Glob Health. 2015;5(2):020415.

   OpenUrl
2. 2.↵
   1. Lozano R,
   2. Naghavi M,
   3. Foreman K,
   4. et al.

   Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2095-2128. doi: 10.1016/S0140-6736(12)61728-0

   OpenUrlCrossRefPubMedWeb of Science
3. 3.↵
   1. Vos T,
   2. Flaxman AD,
   3. Naghavi M,
   4. et al.

   Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2163-2196. doi: 10.1016/S0140-6736(12)61729-2

   OpenUrlCrossRefPubMedWeb of Science
4. 4.↵
   1. Mathers CD,
   2. Loncar D

   . Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006;3(11):e442. doi: 10.1371/journal.pmed.0030442

   OpenUrlCrossRefPubMed
5. 5.↵
   1. Guarascio AJ,
   2. Ray SM,
   3. Finch CK,
   4. Self TH

   . The clinical and economic burden of chronic obstructive pulmonary disease in the USA. Clinicoecon Outcomes Res. 2013;5:235-245. doi: 10.2147/CEOR.S34321

   OpenUrlCrossRefPubMed
6. 6.↵
   1. Singh JA,
   2. Yu S

   . Utilization due to chronic obstructive pulmonary disease and its predictors: a study using the U.S. National Emergency Department Sample (NEDS). Respir Res. 2016;17:1. doi: 10.1186/s12931-015-0319-y

   OpenUrlCrossRefPubMed
7. 7.↵
   1. Biener AI,
   2. Decker SL,
   3. Rohde F

   . Prevalence and treatment of chronic obstructive pulmonary disease (COPD) in the United States. JAMA. 2019;322(7):602. doi: 10.1001/jama.2019.10241

   OpenUrlCrossRef
8. 8.↵
   1. Kirsch F,
   2. Schramm A,
   3. Schwarzkopf L,
   4. et al.

   Direct and indirect costs of COPD progression and its comorbidities in a structured disease management program: results from the LQ-DMP study. Respir Res. 2019;20(1):215. doi: 10.1186/s12931-019-1179-7

   OpenUrlCrossRef
9. 9.↵
   1. Garcia-Aymerich J,
   2. Farrero E,
   3. Félez MA,
   4. Izquierdo J,
   5. Marrades RM,
   6. Antó JM

   ; Estudi del Factors de Risc d'Agudització de la MPOC investigators. Risk factors of readmission to hospital for a COPD exacerbation: a prospective study. Thorax. 2003;58(2):100-105. doi: 10.1136/thorax.58.2.100

   OpenUrlAbstract/FREE Full Text
10. 10.↵
    1. Almagro P,
    2. Barreiro B,
    3. Ochoa de Echaguen A,
    4. et al.

    Risk factors for hospital readmission in patients with chronic obstructive pulmonary disease. Respiration. 2006;73(3):311-317. doi: 10.1159/000088092

    OpenUrlCrossRefPubMedWeb of Science
11. 11.↵
    1. Müllerová H,
    2. Shukla A,
    3. Hawkins A,
    4. Quint J

    . Risk factors for acute exacerbations of COPD in a primary care population: a retrospective observational cohort study. BMJ Open. 2014;4(12):e006171. doi: 10.1136/bmjopen-2014-006171

    OpenUrlAbstract/FREE Full Text
12. 12.
    1. Donaldson GC,
    2. Wedzicha JA

    . COPD exacerbations .1: epidemiology. Thorax. 2006;61(2):164-168. doi: 10.1136/thx.2005.041806

    OpenUrlAbstract/FREE Full Text
13. 13.
    1. Sapey E,
    2. Stockley RA

    . COPD exacerbations. 2: aetiology. Thorax. 2006;61(3):250-258. doi: 10.1136/thx.2005.041822

    OpenUrlAbstract/FREE Full Text
14. 14.↵
    1. Hurst JR,
    2. Vestbo J,
    3. Anzueto A

    , et al; Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Investigators. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med. 2010;363(12):1128-1138. doi: 10.1056/NEJMoa0909883

    OpenUrlCrossRefPubMedWeb of Science
15. 15.↵
    1. Bafadhel M,
    2. Peterson S,
    3. De Blas MA,
    4. et al.

    Predictors of exacerbation risk and response to budesonide in patients with chronic obstructive pulmonary disease: a post-hoc analysis of three randomised trials. Lancet Respir Med. 2018;6(2):117-126. doi: 10.1016/S2213-2600(18)30006-7

    OpenUrlCrossRefPubMed
16. 16.↵
    1. Khialani B,
    2. Sivakumaran P,
    3. Keijzers G,
    4. Sriram KB

    . Emergency department management of acute exacerbations of chronic obstructive pulmonary disease and factors associated with hospitalization. J Res Med Sci. 2014;19(4):297-303.

    OpenUrl
17. 17.↵
    1. Parshall MB,
    2. Doherty GS

    . Predictors of emergency department visit disposition for patients with chronic obstructive pulmonary disease. Heart Lung. 2006;35(5):342-350. doi: 10.1016/j.hrtlng.2006.02.002

    OpenUrlCrossRefPubMed
18. 18.↵
    1. Chandra D,
    2. Tsai CL,
    3. Camargo CA Jr.

    . Acute exacerbations of COPD: delay in presentation and the risk of hospitalization. COPD. 2009;6(2):95-103. doi: 10.1080/15412550902751746

    OpenUrlCrossRefPubMed
19. 19.↵
    1. Quintana JM,
    2. Esteban C,
    3. Garcia-Gutierrez S

    , et al; IRYSS-COPD Group. Predictors of hospital admission two months after emergency department evaluation of COPD exacerbation. Respiration. 2014;88(4):298-306. doi: 10.1159/000365996

    OpenUrlCrossRefPubMed
20. 20.↵
    1. Considine J,
    2. Botti M,
    3. Thomas S

    . Early predictors of hospital admission in emergency department patients with chronic obstructive pulmonary disease. Australas Emerg Nurs J. 2011;14(3):180-188. doi: 10.1016/j.aenj.2011.05.004

    OpenUrlCrossRef
21. 21.↵
    1. Rowe BH,
    2. Villa-Roel C,
    3. Guttman A,
    4. et al.

    Predictors of hospital admission for chronic obstructive pulmonary disease exacerbations in Canadian emergency departments. Acad Emerg Med. 2009;16(4):316-324. doi: 10.1111/j.1553-2712.2009.00366.x

    OpenUrlCrossRefPubMed
22. 22.↵
    1. Montserrat-Capdevila J,
    2. Godoy P,
    3. Marsal JR,
    4. Barbé F.

    Predictive model of hospital admission for COPD exacerbation. Respir Care. 2015;60(9):1288-1294. doi: 10.4187/respcare.04005

    OpenUrlAbstract/FREE Full Text
23. 23.↵
    1. Groenewegen KH,
    2. Schols AMWJ,
    3. Wouters EFM

    . Mortality and mortality-related factors after hospitalization for acute exacerbation of COPD. Chest. 2003;124(2):459-467. doi: 10.1378/chest.124.2.459

    OpenUrlCrossRefPubMedWeb of Science
24. 24.↵
    1. García-Sanz MT,
    2. Pol-Balado C,
    3. Abellás C,
    4. Cánive-Gómez JC,
    5. Antón-Sanmartin D,
    6. González-Barcala FJ

    . Factors associated with hospital admission in patients reaching the emergency department with COPD exacerbation. Multidiscip Respir Med. 2012;7(1):6. doi: 10.1186/2049-6958-7-6

    OpenUrlCrossRefPubMed
25. 25.↵
    1. Tsai CL,
    2. Clark S,
    3. Cydulka RK,
    4. Rowe BH,
    5. Camargo CA Jr..

    Factors associated with hospital admission among emergency department patients with chronic obstructive pulmonary disease exacerbation. Acad Emerg Med. 2007;14(1):6-14. doi: 10.1197/j.aem.2006.07.034

    OpenUrlCrossRefPubMedWeb of Science
26. 26.↵
    1. Chu CM,
    2. Chan VL,
    3. Lin AWN,
    4. Wong IWY,
    5. Leung WS,
    6. Lai CKW

    . Readmission rates and life threatening events in COPD survivors treated with non-invasive ventilation for acute hypercapnic respiratory failure. Thorax. 2004;59(12):1020-1025. doi: 10.1136/thx.2004.024307

    OpenUrlAbstract/FREE Full Text
27. 27.↵
    1. Yohannes AM,
    2. Kaplan A,
    3. Hanania NA

    . Anxiety and depression in chronic obstructive pulmonary disease: recognition and management. Cleve Clin J Med. 2018;85(2 Suppl 1):S11-S18. doi: 10.3949/ccjm.85.s1.03

    OpenUrlFREE Full Text
28. 28.↵
    1. Xu W,
    2. Collet JP,
    3. Shapiro S,
    4. et al.

    Independent effect of depression and anxiety on chronic obstructive pulmonary disease exacerbations and hospitalizations. Am J Respir Crit Care Med. 2008;178(9):913-920. doi: 10.1164/rccm.200804-619OC

    OpenUrlCrossRefPubMedWeb of Science
29. 29.↵
    1. Montserrat-Capdevila J,
    2. Godoy P,
    3. Marsal JR,
    4. et al.

    Overview of the impact of depression and anxiety in chronic obstructive pulmonary disease. Lung. 2017;195(1):77-85. doi: 10.1007/s00408-016-9966-0

    OpenUrlCrossRef
30. 30.↵
    1. Roberts MH,
    2. Clerisme-Beaty E,
    3. Kozma CM,
    4. Paris A,
    5. Slaton T,
    6. Mapel DW

    . A retrospective analysis to identify predictors of COPD-related rehospitalization. BMC Pulm Med. 2016;16(1):68. doi: 10.1186/s12890-016-0231-3

    OpenUrlCrossRefPubMed
31. 31.↵
    1. Gudmundsson G,
    2. Gislason T,
    3. Janson C,
    4. et al.

    Risk factors for rehospitalisation in COPD: role of health status, anxiety and depression. Eur Respir J. 2005;26(3):414-419. doi: 10.1183/09031936.05.00078504

    OpenUrlAbstract/FREE Full Text
32. 32.↵
    1. Fan VS,
    2. Ramsey SD,
    3. Giardino ND

    , et al; National Emphysema Treatment Trial (NETT) Research Group. Sex, depression, and risk of hospitalization and mortality in chronic obstructive pulmonary disease. Arch Intern Med. 2007;167(21):2345-2353. doi: 10.1001/archinte.167.21.2345

    OpenUrlCrossRefPubMedWeb of Science
33. 33.↵
    1. Zhang MWB,
    2. Ho RCM,
    3. Cheung MWL,
    4. Fu E,
    5. Mak A.

    Prevalence of depressive symptoms in patients with chronic obstructive pulmonary disease: a systematic, meta-analysis and meta-regression. Gen Hosp Psychiatry. 2011;33(3):217-223. doi: 10.1016/j.genhosppsych.2011.03.009

    OpenUrlCrossRefPubMedWeb of Science
34. 34.↵
    1. Dalal AA,
    2. Shah M,
    3. Lunacsek O,
    4. Hanania NA

    . Clinical and economic burden of depression/anxiety in chronic obstructive pulmonary disease patients within a managed care population. COPD. 2011;8(4):293-299. doi: 10.3109/15412555.2011.586659

    OpenUrlCrossRef
35. 35.↵
    1. Bremmer MA,
    2. Beekman ATF,
    3. Deeg DJH,
    4. et al.

    Inflammatory markers in late-life depression: results from a population-based study. J Affect Disord. 2008;106(3):249-255. doi: 10.1016/j.jad.2007.07.002

    OpenUrlCrossRefPubMedWeb of Science
36. 36.
    1. Cohen S,
    2. Tyrrell DA,
    3. Smith AP

    . Negative life events, perceived stress, negative affect, and susceptibility to the common cold. J Pers Soc Psychol. 1993;64(1):131-140. doi: 10.1037//0022-3514.64.1.131

    OpenUrlCrossRefPubMedWeb of Science
37. 37.↵
    1. Laurin C,
    2. Moullec G,
    3. Bacon SL,
    4. Lavoie KL

    . Impact of anxiety and depression on chronic obstructive pulmonary disease exacerbation risk. Am J Respir Crit Care Med. 2012;185(9):918-923. doi: 10.1164/rccm.201105-0939PP

    OpenUrlCrossRefPubMedWeb of Science
38. 38.↵
    1. Burgess A,
    2. Kunik ME,
    3. Stanley MA

    . Chronic obstructive pulmonary disease: assessing and treating psychological issues in patients with COPD. Geriatrics. 2005;60(12):18-21.

    OpenUrlPubMed
39. 39.↵
    1. Montserrat-Capdevila J,
    2. Godoy P,
    3. Marsal JR,
    4. Barbé F,
    5. Galván L

    . Risk factors for exacerbation in chronic obstructive pulmonary disease: a prospective study. Int J Tuberc Lung Dis. 2016;20(3):389-395. doi: 10.5588/ijtld.15.0441

    OpenUrlCrossRef